Literature DB >> 9194224

Do CTL kill target cells by inducing apoptosis?

P A Henkart1, M S Williams, C M Zacharchuk, A Sarin.   

Abstract

Inhibitors of ICE-family proteases (caspases) block many examples of apoptotic cell death in vivo and in vitro, including multiple apoptotic stimuli for T lymphocytes. We have tested whether cell death induced by cytotoxic T lymphocytes was also blocked by caspase inhibitors. We found that the rapid apoptotic target cell death induced by Fas ligand-bearing CTL using the target Fas death pathway was efficiently blocked by caspase inhibitors. In contrast, target lysis induced by the CTL granule exocytosis pathway is not detectably blocked by such inhibitors, although the accompanying apoptotic nuclear damage is efficiently blocked. Thus caspase inhibitors prevent the hallmark phenotype of apoptosis without measurably affecting target cell death as evidenced by lysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194224     DOI: 10.1006/smim.1997.0063

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  11 in total

1.  Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.

Authors:  N P Restifo
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

2.  Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation.

Authors:  Joel G R Weaver; Christopher G A McGregor; Henry D Tazelaar; Andrew D Badley
Journal:  J Heart Lung Transplant       Date:  2005-07       Impact factor: 10.247

Review 3.  The role of activation-induced cell death in the differentiation of T-helper-cell subsets.

Authors:  Arthur I Roberts; Satish Devadas; Xiaoren Zhang; Liying Zhang; Achsah Keegan; Kristy Greeneltch; Jennifer Solomon; Lixin Wei; Jyoti Das; Erwei Sun; Catherine Liu; Zengrong Yuan; Jian-Nian Zhou; Yufang Shi
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  MicroRNA-25 Negatively Regulates Cerebral Ischemia/Reperfusion Injury-Induced Cell Apoptosis Through Fas/FasL Pathway.

Authors:  Jun-Feng Zhang; Li-Li Shi; Li Zhang; Zhao-Hua Zhao; Fei Liang; Xi Xu; Ling-Yu Zhao; Peng-Bo Yang; Jian-Shui Zhang; Ying-Fang Tian
Journal:  J Mol Neurosci       Date:  2016-01-14       Impact factor: 3.444

5.  Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes.

Authors:  Jasmin Herz; Julian Pardo; Hamid Kashkar; Michael Schramm; Elza Kuzmenkina; Erik Bos; Katja Wiegmann; Reinhard Wallich; Peter J Peters; Stefan Herzig; Elmon Schmelzer; Martin Krönke; Markus M Simon; Olaf Utermöhlen
Journal:  Nat Immunol       Date:  2009-06-14       Impact factor: 25.606

6.  Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation.

Authors:  T Fan; H Lu; H Hu; L Shi; G A McClarty; D M Nance; A H Greenberg; G Zhong
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

7.  Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice.

Authors:  E K Haddad; X Wu; J A Hammer; P A Henkart
Journal:  J Cell Biol       Date:  2001-02-19       Impact factor: 10.539

8.  Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs.

Authors:  Karolina Bień; Justyna Sokołowska; Piotr Bąska; Zuzanna Nowak; Wanda Stankiewicz; Malgorzata Krzyzowska
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

9.  Adrenal-Derived Hormones Differentially Modulate Intestinal Immunity in Experimental Colitis.

Authors:  Patrícia Reis de Souza; Helioswilton Sales-Campos; Paulo José Basso; Viviani Nardini; Angelica Silva; Fernanda Banquieri; Vanessa Beatriz Freitas Alves; Javier Emílio Lazo Chica; Auro Nomizo; Cristina Ribeiro de Barros Cardoso
Journal:  Mediators Inflamm       Date:  2016-06-14       Impact factor: 4.711

10.  Therapeutic cancer vaccines in prostate cancer: the quest for intermediate markers of response.

Authors:  Joseph W Kim; Marijo Bilusic; Christopher J Heery; Ravi A Madan
Journal:  Cancers (Basel)       Date:  2012-11-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.